Diese Website verwendet Cookies, damit wir dir die bestmögliche Benutzererfahrung bieten können. Cookie-Informationen werden in deinem Browser gespeichert und führen Funktionen aus, wie das Wiedererkennen von dir, wenn du auf unsere Website zurückkehrst, und hilft unserem Team zu verstehen, welche Abschnitte der Website für dich am interessantesten und nützlichsten sind.
Transforming Cancer Diagnosis
- Used by pathologists in everyday practice
- Clinical grade accuracy
- Improved productivity and shorter turnaround time
- Reduced error rate and 100% quality control
- AI-based diagnostic tools: case prioritization worklist, slide viewer, IHC preordering, cancer heatmaps, grading, measurements, non-cancer findings, AI-driven reporting
Gastric cancer is among the most common malignant diseases in both men and women worldwide, with over a million new cases each year. Accurate and timely diagnosis is instrumental in guiding treatment decisions and improving survival rates.
However, accurate and rapid analysis of gastric biopsies remains a challenge, as increasing case volumes are intensified by subjectivity in detecting cancer, low percentage of cancer vs. benign cases, difficulty in detecting H. pylori and multiple other reasons.
Powered by AI and serving the world’s leading physicians, health systems
and diagnostic providers, Ibex’s Gastric solution is a clinical-grade solution that assists pathologists in improving the detection of gastric cancer and other clinical findings.
H. pylori related gastritis heatmap
Neuroendocrine neoplasms heatmap
Read in Forbes: A New AI Technology Might Help Detect Gastric Cancer
Listen to this podcast with Ibex’s CTO, Dr. Chaim Linhart, discussing the unique challenges and opportunities for unlocking the tools of digital pathology.
Ibex’s gastric solution is CE marked (IVDD). It is for Research Use Only (RUO) in the United States and not cleared by the FDA. Contact us for more information, including indication for use and regulatory approval in other countries.